trending Market Intelligence /marketintelligence/en/news-insights/trending/I3gswYuG-3r6s8X4cEesGg2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

The VC Beat: Kyverna Therapeutics gets $25M; Zipari lands $22.5M in financing

Street Talk - Ep. 64: Coronavirus jumpstarts digital adoption

Street Talk Podcast

Street Talk - Ep. 63: Deal talks continue amid bank M&A freeze, setting up for strong Q4

Street Talk Podcast

Street Talk - Ep. 62: 'Brutal' outlook for oil demand offers banks in oil patch no relief

Amid Q1 APAC Fintech Funding Slump, Payment Companies Drove Investments


The VC Beat: Kyverna Therapeutics gets $25M; Zipari lands $22.5M in financing

This feature rounds up venture capital news and highlights larger deal coverage already published.

* Cell therapy company Kyverna Therapeutics, which engineers a new class of autoimmune disease therapies, secured $25 million in series A funding from Vida Ventures, Westlake Village BioPartners and Gilead Sciences Inc.

* A $22.5 million series B financing round for health insurance consumer platform Zipari Inc. was led by Vertical Venture Partners, with participation from Health Velocity Capital; CareFirst BlueCross BlueShield's healthcare investment and innovation unit, Healthworx; and Horizon Healthcare Services Inc.

* Balderton Capital led a €12.7 million funding round for U.K.-based flexible business school Jolt, EU-Startups reported.

Additional coverage

Biopharma firm Transcenta raises US$100M in financing round

Nference raises $60M in 2nd round of financing for biomedical platform

Unless otherwise noted, historical funding data is sourced from the S&P Global Market Intelligence platform.